Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02886715

Public ClinicalTrials.gov record NCT02886715. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both Active Treatments to a Vehicle Control in the Treatment of Acne Vulgaris

Study identification

NCT ID
NCT02886715
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Fougera Pharmaceuticals Inc.
Industry
Enrollment
1,110 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2016 (Actual)
Primary completion
May 31, 2017 (Actual)
Completion
May 31, 2017 (Actual)
Last update posted
Aug 17, 2018

2016 – 2017

United States locations

U.S. sites
25
U.S. states
9
U.S. cities
23
Facility City State ZIP Site status
Fougera Investigational Site Tucson Arizona 85712 —
Fougera Investigational Site Conway Arkansas 72034 —
Fougera Investigational Site Hot Springs Arkansas 71913 —
Fougera Investigational Site Anaheim California 92801 —
Fougera Investigational Site La Mesa California 91942 —
Fougera Investigational Site Long Beach California 90806 —
Fougera Investigational Site Long Beach California 90813 —
Fougera Investigational Site Los Angeles California 90010 —
Fougera Investigational Site North Hollywood California 91606 —
Fougera Investigational Site San Diego California 92108 —
Fougera Investigational Site San Ramon California 94582 —
Fougera Investigational Site Upland California 91786 —
Fougera Investigational Site West Covina California 91790 —
Fougera Investigational Site Coral Gables Florida 33134 —
Fougera Investigational Site Miami Florida 33015 —
Fougera Investigational Site Miami Florida 33175 —
Fougera Investigational Site Miami Gardens Florida 33169 —
Fougera Investigational Site Miramar Florida 33027 —
Fougera Investigational Site Sweetwater Florida 33172 —
Fougera Investigational Site Plainfield Indiana 46168 —
Fougera Investigational Site High Point North Carolina 27262 —
Fougera Investigational Site Hazleton Pennsylvania 18201 —
Fougera Investigational Site Upper Saint Clair Pennsylvania 15241 —
Fougera Investigational Site Chattanooga Tennessee 37421 —
Fougera Investigational Site Austin Texas 78759 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02886715, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2018 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02886715 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →